Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3708826014 | Product containing bismuth biskalcitrate and metronidazole and tetracycline in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3708827017 | Bismuth biskalcitrate- and metronidazole- and tetracycline-containing product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4561481000052118 | läkemedel som innehåller metronidazol, tetracyklin och vismutbiskalcitrat, oral läkemedelsform | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing bismuth biskalcitrate and metronidazole and tetracycline in oral dose form (medicinal product form) | Has active ingredient | Tetracycline (substance) | true | Inferred relationship | Some | 2 | |
| Product containing bismuth biskalcitrate and metronidazole and tetracycline in oral dose form (medicinal product form) | Is a | Metronidazole-containing product in oral dose form | true | Inferred relationship | Some | ||
| Product containing bismuth biskalcitrate and metronidazole and tetracycline in oral dose form (medicinal product form) | Has active ingredient | Bismuth biskalcitrate (substance) | true | Inferred relationship | Some | 3 | |
| Product containing bismuth biskalcitrate and metronidazole and tetracycline in oral dose form (medicinal product form) | Is a | Product containing tetracycline in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing bismuth biskalcitrate and metronidazole and tetracycline in oral dose form (medicinal product form) | Has active ingredient | Metronidazole (substance) | true | Inferred relationship | Some | 1 | |
| Product containing bismuth biskalcitrate and metronidazole and tetracycline in oral dose form (medicinal product form) | Is a | Product containing bismuth biskalcitrate and metronidazole and tetracycline (medicinal product) | true | Inferred relationship | Some | ||
| Product containing bismuth biskalcitrate and metronidazole and tetracycline in oral dose form (medicinal product form) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
| Product containing bismuth biskalcitrate and metronidazole and tetracycline in oral dose form (medicinal product form) | Plays role | Antibacterial therapeutic role (role) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| metronidazol 125 milligram, tetracyklin 125 milligram och vismutbiskalcitrat 140 milligram, oral kapsel | Is a | False | Product containing bismuth biskalcitrate and metronidazole and tetracycline in oral dose form (medicinal product form) | Inferred relationship | Some | |
| Bismuth biskalcitrate and metronidazole and tetracycline only product in oral dose form | Is a | True | Product containing bismuth biskalcitrate and metronidazole and tetracycline in oral dose form (medicinal product form) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR